A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration
Clinical trial NCT03869684 · TERMINATED
Trial details
- NCT number
- NCT03869684
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-25
- Primary completion
- 2020-03-25
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.